rs10858278

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000093.5(COL5A1):​c.1936-35C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0692 in 1,609,784 control chromosomes in the GnomAD database, including 8,620 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 2264 hom., cov: 33)
Exomes 𝑓: 0.063 ( 6356 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.202

Publications

5 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 9-134761890-C-A is Benign according to our data. Variant chr9-134761890-C-A is described in ClinVar as Benign. ClinVar VariationId is 255059.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.282 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.1936-35C>A intron_variant Intron 18 of 65 ENST00000371817.8 NP_000084.3
COL5A1NM_001278074.1 linkc.1936-35C>A intron_variant Intron 18 of 65 NP_001265003.1
COL5A1XM_017014266.3 linkc.1936-35C>A intron_variant Intron 18 of 64 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.1936-35C>A intron_variant Intron 18 of 65 1 NM_000093.5 ENSP00000360882.3
COL5A1ENST00000371820.4 linkc.1936-35C>A intron_variant Intron 18 of 65 2 ENSP00000360885.4

Frequencies

GnomAD3 genomes
AF:
0.131
AC:
19955
AN:
152132
Hom.:
2257
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.286
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.167
Gnomad ASJ
AF:
0.0825
Gnomad EAS
AF:
0.271
Gnomad SAS
AF:
0.121
Gnomad FIN
AF:
0.0316
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0393
Gnomad OTH
AF:
0.107
GnomAD2 exomes
AF:
0.116
AC:
28964
AN:
250734
AF XY:
0.104
show subpopulations
Gnomad AFR exome
AF:
0.294
Gnomad AMR exome
AF:
0.253
Gnomad ASJ exome
AF:
0.0878
Gnomad EAS exome
AF:
0.277
Gnomad FIN exome
AF:
0.0338
Gnomad NFE exome
AF:
0.0405
Gnomad OTH exome
AF:
0.0876
GnomAD4 exome
AF:
0.0627
AC:
91377
AN:
1457534
Hom.:
6356
Cov.:
30
AF XY:
0.0624
AC XY:
45262
AN XY:
725312
show subpopulations
African (AFR)
AF:
0.290
AC:
9667
AN:
33384
American (AMR)
AF:
0.242
AC:
10819
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0854
AC:
2230
AN:
26098
East Asian (EAS)
AF:
0.270
AC:
10694
AN:
39670
South Asian (SAS)
AF:
0.118
AC:
10148
AN:
86196
European-Finnish (FIN)
AF:
0.0344
AC:
1814
AN:
52722
Middle Eastern (MID)
AF:
0.0823
AC:
474
AN:
5756
European-Non Finnish (NFE)
AF:
0.0367
AC:
40741
AN:
1108762
Other (OTH)
AF:
0.0795
AC:
4790
AN:
60244
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4413
8826
13240
17653
22066
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1932
3864
5796
7728
9660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.131
AC:
20008
AN:
152250
Hom.:
2264
Cov.:
33
AF XY:
0.132
AC XY:
9804
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.286
AC:
11871
AN:
41518
American (AMR)
AF:
0.168
AC:
2570
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0825
AC:
286
AN:
3468
East Asian (EAS)
AF:
0.272
AC:
1408
AN:
5182
South Asian (SAS)
AF:
0.120
AC:
581
AN:
4828
European-Finnish (FIN)
AF:
0.0316
AC:
335
AN:
10616
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0394
AC:
2677
AN:
68022
Other (OTH)
AF:
0.108
AC:
228
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
798
1595
2393
3190
3988
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.106
Hom.:
397
Bravo
AF:
0.151
Asia WGS
AF:
0.212
AC:
734
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.8
DANN
Benign
0.68
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10858278; hg19: chr9-137653736; COSMIC: COSV65666812; API